The state of the fight:South Africa’s Biovac will fill-finish the Pfizer/BioNTech vaccine.
The U.S. will give $200 million to South Africa’s Aspen Pharmacare to boost vaccine capacity.
CEPI and IVI are backing new vaccine trials in Africa.
Sanofi’s “Vidprevtyn” under rolling review: The EMA announced Tuesday it has begun reviewing the recombinant protein Covid-19 vaccine candidate, which uses a GSK adjuvant. Sanofi also expects real…